BFS
DYN icon

Bare Financial Services’s Dyne Therapeutics DYN Stock Holding History

Bare Financial Services’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28
Closed -$508 – 1824
2026
Q1 		$508 Buy
+28
New +$483 ﹤0.01% 1516

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bare Financial Services's DYN Position: Q2 2026 in Review

Bare Financial Services sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 28 shares — an estimated $508 sold.

Bare Financial Services first reported a position in DYN in Q1 2026 and held it in 1 quarter. The position peaked at $508 in Q1 2026. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Bare Financial Services reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Bare Financial Services sold 28 Dyne Therapeutics shares in Q2 2026, an estimated $508.
  • Bare Financial Services first reported a position in Dyne Therapeutics in Q1 2026 and held it in 1 quarter.
  • Bare Financial Services's Dyne Therapeutics position peaked at $508 in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.